IBC Life Sciences Kicks Off the Annual BioProcess International(TM) Conference &Amp; Exhibition in Anaheim, California
Posted on: Monday, 22 September 2008, 15:00 CDT
Today IBC Life Sciences kicks off its annual BioProcess International(TM) Conference & Exhibition in Anaheim, California. 1,500 pharmaceutical, biotechnology, government and academic researchers, executives and technology providers are expected to attend.
This year the event features six conference keynote presenters who will provide inspiration for a streamlined industry. Keynote presenters include senior executives from Genentech, Inc, Pfizer, Inc, NASA Jet Propulsion Laboratory, Eli Lilly and Co., Genzyme Corp, and Computer Sciences Corporation.
In addition, a special exhibit hall presentation will be delivered on Wednesday evening, September 24 by Prof. Charles L. Conney from MIT entitled "The Treacherous Path to Success in the Biotech Industry."
The conference program runs September 22-26 and is divided into 3 pre-conference workshops on Monday, September 22 and 4 main conference tracks that run concurrently on September 23-26. The four conference tracks are: production & economics of biopharmaceuticals, scaling up from bench through commercialization, cell culture & upstream processing and recovery & purification.
The sold out exhibit hall is open September 23-25, with over 150 bioprocessing technology exhibitors. The exhibition opens Tuesday, September 23 at 5:30 pm, with a welcome reception sponsored by SAFC Biosciences. Hall hours are Tuesday, September 23, from 5:30 pm to 7:00 pm; Wednesday, September 24, from 9:45 am to 7:15 pm, and Thursday, September 25 from 9:45 am to 4:00 pm. Exhibit hall viewing passes are still available.
The event will take place at the Disneyland(R) Hotel on September 22-26, 2008. For complete event details visit www.IBCLifeSciences.com/BPI/US.
About IBC Life Sciences
IBC Life Sciences is the worldwide leader in scientific, technological and business conferences and courses for the life science industry. To develop its programs, IBC actively researches the advancements, technologies and trends impacting and driving the race for new drugs and therapies. No other organization can make claim to the breadth and quality that IBC Life Sciences delivers in each event giving the company recognition around the globe for quality, service and value. For more information, visit: http://www.IBCLifeSciences.com.
Contact: Dawn O'Connor IBC Life Sciences 508 - 614 - 1679 Email Contact
SOURCE: IBC Life Sciences
Source: MARKET WIRE
Related Articles
- BiPar Sciences to Present at Pacific Growth Equities Life Sciences Growth Conference on June 14, 2006
- Point Therapeutics to Present at the Pacific Growth Equities Life Sciences Growth Conference
- ChemGenex To Present At Pacific Growth Equities 2006 Life Sciences Growth Conference
- OraSure Technologies to Present at Pacific Growth Equities Life Sciences Growth Conference
- CombinatoRx to Present at the Pacific Growth Equities Life Sciences Growth Conference
- Dynavax to Present at Pacific Growth Equities 2006 Life Sciences Growth Conference
- Reliant Pharmaceuticals to Present at Pacific Growth Equities Life Sciences Growth Conference
- Penwest to Present at Pacific Growth Equities 2006 Life Sciences Growth Conference
- Cytori Therapeutics to Present at the Pacific Growth Equities Life Sciences Growth Conference
- Pacific Growth Equities Announces 2006 Life Sciences Growth Conference
User Comments (0)

RSS Feeds